NCMP-17 Emergent Neurosurgical Intervention for Intra-Axial Brain Tumors: Presentation Patterns, Operative Strategies, and Early Outcomes in a 20-Year Single-Center Cohort
Abstract
Most neurosurgical tumor series focus on elective resection or single tumor types, leaving the population requiring emergent intervention poorly characterized. This study describes emergent neurosurgical intervention for intra-axial tumors across pathologies and age groups and identifies exploratory predictors of early outcomes. All patients undergoing emergent neurosurgical intervention for an intra-axial tumor or tumor-related complication at Mayo Clinic Rochester (2004–2024) were retrospectively analyzed. The primary outcome was 30-day mortality. Poor three-month outcome was defined as death before three months or inability to resume work/activities of daily living. Adult–pediatric comparisons used Fisher exact and Mann–Whitney U tests. Exploratory univariable odds ratios with Benjamini–Hochberg correction were estimated. Eighty-two patients were identified (median age 45.5 years; 20.7% pediatric). Diffuse glioma (34.1%) and metastasis (28.0%) predominated. Herniation signs on imaging were present in 44.4% with median midline shift of 10.0 mm. Emergent resection was performed in 52.4%, CSF diversion alone in 20.7%, and decompression alone in 12.2%. Thirty-day mortality was 14.6%, death before three months 23.8%, and poor three-month outcome 63.5%. Diffuse glioma and metastasis accounted for 75% of 30-day deaths. No pediatric patient died before three months. After correction, enhancing lesions (OR 42.23; q = 0.004), high-grade histology (OR 6.03; q = 0.022), and hemiparesis (OR 20.61; q = 0.022) were associated with poor three-month outcomes. Emergent neurosurgical intervention for intra-axial tumors carries substantial early mortality and disability. Tumor biology and decompensation phenotype were more informative than age alone, emphasizing pathology-specific counseling and triage in emergency neuro-oncologic care.